PPHM gets oomph, GE trades widely, NAII loses strength

Peregrine Pharmaceuticals Inc. (Nasdaq: PPHM) added 34.34 percent in price Monday to close at $2.23. Volume of 3,418,741 shares proved more than five times its daily average. The Calif.-based PPHM, a clinical-stage biopharmaceutical company today announced the completion of enrollment in the company’s Phase II dose confirmation trial of Cotara® in patients with recurrent glioblastoma multiforme (GBM), the deadliest form of brain cancer.

General Electric Company (NYSE: GE) traded in 40,410,548 shares, making it a volume leader, but falling short of its daily average of 59,801,500. Share prices were flat at $17.70. GE has received and is reviewing the engineering performance standards issued today by the U.S. Environmental Protection Agency for the second phase of the Hudson River dredging project, one of the largest environmental cleanups ever conducted in the United States.

Natural Alternatives International Inc. (Nasdaq: NAII) gave back 13.97 percent in price Monday to $5.85, on volume of 231,737 shares, swarming its daily average of 15,446. NAII, based in San Marcos, Calif., is a leading formulator, manufacturer and marketer of customized nutritional supplements.

Tags: GE, healthcare, NAII, nasdaq, NYSE, pharmaceutical stocks, PPHM, Technology Stocks

This entry was posted on Monday, December 20th, 2010 at 5:05 pm by Glenn and is filed under Health Care Stocks, Technology Stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.